Mr. Nobendu Mukerjee | Biochemistry | Young Scientist Award
University of Houston | India
Nobendu Mukerjee is an emerging researcher in cancer biology and microbiology, dedicated to bridging bioinformatics and wet-lab research to uncover molecular mechanisms driving cancer progression and to develop novel therapeutic strategies. He holds an M.Sc. in Microbiology from West Bengal State University with an outstanding CGPA of 9.78, following a B.Sc. (Hons.) in Microbiology from Ramakrishna Mission Vivekananda Centenary College. His research primarily focuses on exosome-mediated PROTAC delivery systems and phytochemical-based cancer therapies. During his academic journey, Nobendu has gained significant research experience at reputed institutions such as the A*STAR Institute of Molecular and Cell Biology (Singapore), Tripura University, St. Xavier’s College Kolkata, Sambalpur University, and Banaras Hindu University. His work explores therapeutic nanodelivery, protein–ligand interactions, and computational drug design aimed at targeted cancer treatments. As a first author in multiple high-impact publications across journals like Chemical Engineering Journal, Drug Discovery Today, ACS Applied Nano Materials, and Journal of Medical Virology, he has made valuable contributions to the fields of cancer therapeutics, exosome biology, and molecular medicine. His excellence has been recognized through prestigious fellowships, including the Singapore International Pre-Graduate Award (SIPGA) and the SPARK Fellowship from IIT Roorkee & BHU. Currently serving as a Lecturer at Saveetha Medical College and Hospital, Chennai, Nobendu remains committed to advancing precision medicine through integrative bioengineering approaches. His vision is to translate laboratory innovations into clinically transformative cancer therapies that can reshape the future of oncology.
Featured Publications
-
Mukerjee, N., Maitra, S., Kaur, M., Rekha, M. M., Soothwal, P., Arora, I., Thorat, N. D., Sharma, P. K., & Kaushik, A. (2025). Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics. Chemical Engineering Journal, 475, 160915.
-
Mohite, P., Puri, A., Munde, S., Yadav, V., Mukerjee, N., Patil, R., Mahindrakar, N., Siva Prasad, G. V., Verma, R., & Sinha, A. (2025). Exosome-mediated intercellular communication and PROTACs delivery: A dual approach for precision therapy in colon cancer. Journal of Drug Delivery Science and Technology, 87, 106596.
-
Mukerjee, N., Maitra, S., Ghosh, A., Alexiou, A., & Thorat, N. D. (2024). Exosome-mediated PROTAC delivery for treatment of RNA viral infections and zoonosis. Drug Discovery Today, 29(5), 104044.
-
Dhar, R., Mukerjee, N., Mukherjee, D., Devi, A., Jha, S. K., & Gorai, S. (2024). Plant-derived exosomes: A new dimension in cancer therapy. Phytotherapy Research, 38(7), 7828.
-
Mukerjee, N., Maitra, S., & Sharma, R. (2024). Proteolysis-targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome-mediated delivery for targeted protein degradation and therapeutic advancements. Drug Development Research, 85(4), 22145.